Annandale, NJ, United States of America

Robert Allan Farr

This inventor holds 2 USPTO granted patents and 2 EPO patents. Top assignee: Sanofi. Active years: 2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Robert Allan Farr. Retrieved from https://idiyas.com/inventor/robert-allan-farr

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


 

Average Co-Inventor Count = 3.4

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Annadale, NJ (US) (2014)
  • Bridgewater, NJ (US) (2014)

Company Filing History:


Years Active: 2014

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Robert Allan Farr

Introduction

Robert Allan Farr is a notable inventor based in Annandale, NJ (US). He has made significant contributions to the field of pharmaceuticals, holding a total of 2 patents. His work focuses on innovative processes and compounds that have potential applications in medicine.

Latest Patents

Farr's latest patents include a process for the preparation of 2-(cyclohexylmethyl)-N-{2-[(2S)-1-methylpyrrolidin-2-yl]ethyl}-1,2,3,4-tetrahydroisoquinoline-7-sulfonamide. This industrially applicable process is crucial for preparing this compound and its salts. Additionally, he has developed fumarate salts of a histamine H3 receptor antagonist, which relates to pharmaceutical compositions and methods of use.

Career Highlights

Robert Allan Farr is currently associated with Sanofi, a leading global healthcare company. His work at Sanofi emphasizes the development of innovative pharmaceutical solutions that address various health challenges.

Collaborations

Farr has collaborated with notable coworkers such as Beverly C Langevin and Dinubhai H Shah, contributing to a dynamic research environment that fosters innovation.

Conclusion

Robert Allan Farr's contributions to the field of pharmaceuticals through his patents and work at Sanofi highlight his role as a significant inventor. His innovative processes and compounds continue to advance medical science and improve patient care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…